|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-2-20
|
|
pubmed:abstractText |
Clinical staging modalities for esophageal cancer are inaccurate at determining prognosis, especially in early-stage patients. We performed a retrospective review of patients with esophageal adenocarcinoma imaged by positron emission tomography before surgical resection to determine whether 18[F]-fluorodeoxyglucose uptake predicted overall survival independently of clinical and pathologic stage.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
81
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1076-81
|
|
pubmed:meshHeading |
pubmed-meshheading:16488726-Adenocarcinoma,
pubmed-meshheading:16488726-Biological Transport,
pubmed-meshheading:16488726-Esophageal Neoplasms,
pubmed-meshheading:16488726-Fluorodeoxyglucose F18,
pubmed-meshheading:16488726-Follow-Up Studies,
pubmed-meshheading:16488726-Gastrectomy,
pubmed-meshheading:16488726-Humans,
pubmed-meshheading:16488726-Neoplasm Staging,
pubmed-meshheading:16488726-Positron-Emission Tomography,
pubmed-meshheading:16488726-Predictive Value of Tests,
pubmed-meshheading:16488726-Radiopharmaceuticals,
pubmed-meshheading:16488726-Retrospective Studies,
pubmed-meshheading:16488726-Sensitivity and Specificity,
pubmed-meshheading:16488726-Survival Analysis,
pubmed-meshheading:16488726-Tomography, X-Ray Computed
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
|
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. rizkn@mskcc.org
|
|
pubmed:publicationType |
Journal Article
|
